Dear
This attachment contains some of the papers I need...
If you can help me to get some of them, I will be so grateful....
Best regards
Validation of pyridinoline, deoxypyridinoline and hydroxyproline HPLC methods in adult female rhesus monkey urine
Journal Osteoporosis International
Publisher Springer London
ISSN 0937-941X (Print) 1433-2965 (Online)
Issue Volume 6, Supplement 1 / January, 1996
Category Poster Session Abstracts
DOI 10.1007/BF02500277
Page 185
Subject Collection Medicine
SpringerLink Date Thursday, October 12, 2006
N. Ayotte1, L. Huard1 and Y. Deschamps1
(1) Bio-Research Laboratories Ltd., Senneville, Québec, Canada
1. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD.
Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
Bone and Mineral 1990; 8: 87-96
2. Sekine K, Horie H, Hata K.
Determination of pyridinoline and deoxypyridinoline in urine by high-performance liquid chromatography with fluorometric detection.
Rinshou-Kagaku 1992; 21
3. Horie H, Sekine K, Matsuyama M, Aoki N, Hata K.
Determination of pyridinoline and deoxypyridinoline in urine.
Rinshou-Kensa, 1993; 37 (4): 384-8 (In Japanese).
4. Hata K, Miura M, Fukumoto S, Matsumoto T.
Assay of serum Pyridinoline: a potential marker for bone resorption.
Clinica Chimica Acta 1995; 235: 221-7.
5. Meyer-Sabellek W, Slabs P, Kottgen E.
Alkaline phosphatase: laboratory and clinical implications.
J Chromatogr 1988; 429: 419-44.
6. Van Straalen JP, Sanders E, Prummel MF, SandersGTB.
Bone-alkaline phosphatase as indicator of bone formation.
Clinica Chimica Acta 1991; 201 :27-34.
7. Wlodarskl KH, Reddi AH.
Alkaline phosphatase as a marker of osteoinductive cells.
Ca/cjfTissue mt 1986; 39:382-5.
8. Mueller A, Hein G, Franke S et al.
Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography.
Rheumatol Int 1996;16:238.
9. Pearce D, Fisher E, Randall A, Will R, Kent GN, Garcia-Webb P.
Urinary levels of pyridinoline and deoxypyridinoline may be influenced by turnover of non-osseous tissues in patients with joint disease.
Br J Rheumatol 1995;34:11867.
10. Hein G, Franke S, Mueller A, Braeunig E, Eidner T, Stein G.
The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis.
Clin Rheumatol 1997; 16:16772.
11. James I, Crowley C, Perrett D.
Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high performance liquid chromatography.
J Chromatogr 1993;612:418.
12. Colwell A, Russell RG, Eastell R.
Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption.
Eur J Clin Invest 1993;23:3419.
13. Palmerini CA, Fini C, Floridi A, Morelli H, Vedovelli A.
High-performance liquid chromatographic analysis of free hydroxyproline and proline in blood plasma and of free and peptide-bound hydroxyproline in urine.
J Chromatogr 1985;339:28592.
14. Eyre DR, Koob JJ, van Ness KP.
Quantitation of hydroxypyridinium crosslinks by HPLC.
Anal Biochem 1984;137:3808.
15. Spector TD, James IT, Hall GM, Thompson PW, Perrett D, Hart DJ.
Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis.
Clin Rheumatol 1993;12:2404.
16. Delmas PD, Schlemmer A,Gineyts E, Riis B, Christiansen C.
Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patient with vertebral osteoporosis.
J Bone Miner Res 1991;6:63944.
17. Chen JR, Takahashi M, Kushida K et al.
Direct detection of crosslinks of collagen and elastin in the hydrolysates of human yellow ligament using single-column high performance liquid chromatography.
Anal Biochem 2000; 278:99105.
18. Lau KHW, Onishi T, Wergedal JE, Singer FR, Baylink DJ.
Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption.
Clin Chem 1987;33:45862.
19. Minkin C.
Bone acid phosphatase: tartrate-resistant acid phosphatase
as a marker of osteoclast function.
Calcif Tissue Int 1982; 34:28590.
20. Delmas P.
Biochemical markers of bone turnover for the clinical
assessment of metabolic bone disease.
Endocrinol Metab Clin North Am. 1990;19:1-18.
21. Niell HB, Neely CL, Palmieri GM, McDonald MW.
The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
Cancer. 1983;52:1442-7.
22. Black D, Duncan A, Robins SP.
Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed- phase high-performance liquid chromatography.
Anal Biochem. 1988;169:197-203.
23. Robins SP, Stewart P, Astbury C, Bird HA.
Measurement of the crosslinking compound pyridinoline in urine as an index of collagen degradation in joint disease.
Ann Rheum Dis. 1986;45:969-73.
24. Hassager C, Colwell A, Assiri AMA, Eastell R, Russell RGG, Christiansen C.
Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
Chin Endocrinol 1992;37:45-50.
25. Delmas PD.
Biochemical markers of bone turnover for the clinical investigation of osteoporosis.
Osteoporosis mt 1993;3 (Suppl 1):S81-6.
26. Eastell R, Hampton L, Colwell A, Green JR. Assiri AMA,
Heap R, et al.
Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption.
In: Christiansen C, Overgaard K, eds. Osteoporosis 1990 Copenhagen.
Copenhagen: Osteopress, 1990:469-70.
27. Black D, Marabani M, Sturrock RD, Robins SP.
Urinary excretion of the hydroxypyridinium cross links of collagen in
patients with rheumatoid arthritis.
Ann Rheum Dis 1989;48: 641-4.
28. Arrigoni M, Abbiati G, Galimberti S, Longoni A, Bartucci F.
Free and total urinary pyridinoline and deoxypyridinoline analysis:
comparison between 24 hrs collection and fasting early
morning urine samples values.
In: Christiansen C, Overgaard K, eds. Osteoporosis 1990 Copenhagen. Copenhagen: Osteopress, 1990:596-8.
29. Abbiati G, Rigoldi M, Arrigoni M, Longoni A, Fincato G.
Weekly monitoring of free and total urinary pyridinoline and deoxypyridinoline in healthy volunteers.
In: Christiansen C, Overgaard K, eds. Osteoporosis 1990 Copenhagen. Copenhagen: Osteopress, 1990:613-5.
30. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL,
Russell RGG.
Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for bone formation and bone resorption.
Osteoporosis int 1993;3:255-60.
31. Lian JB, Gundberg CM.
Osteocalcin. Biochemical considerations and clinical applications.
Clin Orthop 1988;226:26791.
32. Dessauer A.
Analytical requirements for biochemical bone marker assays.
Scand J Clin Lab Investig 1997;227:849.
33. Pratt DA, Daniloff Y, Duncan A, Robins SP.
Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography.
Anal Biochem 1992;207:16875.
34. Samma S, Kagebayashi Y, Yoneda T, Fukui Y, Yoshida K, Hirao Y et al.
Plasma pyridinium crosslinks as markers of renal osteodystrophy in patients on maintenance hemodialysis.
Nippon Tosekiryoho Gakkai Zasshi 1994;27: 123540 (in Japanese).
35. Kagebayashi Y, Samma S, Yoneda T, Arai K, Yoshida K, Maruyama Y et al.
Measurement and clinical significance of serum concentrations of pyridinium cross-links in patients with renal osteodystrophy.
Nippon Jinzo Gakkai Zasshi 1995;37:397403. (in Japanese)
36. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL.
Collagen cross-link metabolites in urine as markers of bone metastasis in prostatic carcinoma.
J Urol 1994;151:90913.
37. Sano M, Kushida K, Takahashi T,Ohishi K, Kawana K, Okada M, Inoue T.
Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone matastasis.
Brit J Cancer 1994;70:7013.
38. Stepan JJ, Mikulecky M, Bek V, Broulik P, Pacovsky V.
Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Neoplasma 1989;36:495501.
39. Gielen F, Dequeker J, Drochmans A, Wildiers J, Merlevede M.
Relevance of hydroxyproline exeretion to bone metastasis in breast cancer.
Brit J Cancer 1976;34:27985.
40. Fujimoto D, Moriguchi T, Ishida T, Hayashi H.
The structure of pyridinoline, a collagen crosslink.
Biochem Biophys Res Commun 1978;84:527.
41. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ.
Changes in markers of bone formation and resorption in a bed rest model of weightlessness.
J Bone Miner Res 1993;8:14338.
42. Skinner SJ.
Rapid method for the purification of the elastin cross-links, desmosine and
isodesmosine.
J Chromatogr 229: 200-204, 1982.
43. Woessner JF, Jr.
The determination of hydroxyproline in tissue and protein samples containing proportions of this amino acid.
Archives of Biochemistry and Biophysics 93: 440-
447, 1961.
44. HansonDA, Eyre DR. J Bone Min Res. 1991;6 [Sup& l]:A669.
45. Krane SM, Kantmwitz FG, Byrne M, Pinnell SR, Singer FR. 1977
Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
J Clin Invest. 59:819-827.
46. Moro L, Battista C, Modricky C, Rovis L, de Bernard 8.1989
High-performance liquid chromatographic preparation of galactosyl-hydroxylysine, a specific bone collagen marker.
J Chrom. 490~285-292.
47. Kamel S, Brazier M, Desmet G, Picard C, Mennecier I, Sebert JI. 1992
High-performance liquid chromatographic determination of 3
hydroxypyridinium derivatives as new markers of bone resorption.
J Chrom. 574255-260.
48. Askenasi R. 1975
Urinary excretion of free hydroxylysine, peptide-bound hydroxylysine and hydroxylysyl glycosides in physiological conditions.
Clin Chim Acta. 59:87-92.
49. Uebelhart D, Ginetys E, Chapuy MC, Delmas PD. 1990
Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseases.
Bone Miner. 8:87-96.
50. Moro L, Modricky C, Rovis L, de Bernard B. 1988
Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women.
Bone Miner. 3:271-276.
51. Uebelhart D, Schklemmer A, Johansen J, Ginetys E, Christiansen C.Delmas PD. 1991
Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks.
J Clin Endocrinol Metab. 72:367-
373.
52. Bettica P, Moro L. 1993
Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison.
Eur J Clin Chem Clin Biochem. 31:459-465.
53. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T:
Analysis of pyridinoline, a cross-linking compound of collagen fibers in human urine.
J Biochem 94:1133, 1983
54. Robins SP, Duncan A, Riggs BL:
Direct measurement of free hydroxypyridinium cross-links of collagen in urine as new markers of bone resorption in osteoporosis,
in Christiansen CC, Overgaard (eds): Osteoporosis 1990. Copenhagen, Denmark, Osteopress, 1990, p 465
55. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ:
Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
J Bone Miner Res 10:1643, 1994
56. Kamel S, Brazier M, Neri V, Picard C, Samson L, Desmet G, Sebert JL:
Multiple molecular forms of pyridinoline cross-links excreted in human urine evaluated by chromatographic and immuno- assay methods.
J Bone Miner Res 10:1385, 1995
57. Robins SP, Stewart P, Astbury C, Bird HA:
Measurement of cross-link compound pyridinoline in urine as an index of collagen degradation.
Ann Rheum Dis 45:969, 1986
58. Arakawa, N : Kim, M : Otsuka, M
An improved high-performance liquid chromatographic assay for the determination of pyridinoline in connective tissues.
J-Nutr-Sci-Vitaminol-(Tokyo). 1992 Aug; 38(4): 375-80
59. Cloos, Wahl, Hasslacher, Traber, Kistner, Jurkuhn, Schmidt-Gayk (1998)
Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus
Clinical Endocrinology 48 (3), 317323.
60. Bjellerup P. Dept. of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.
Standardization of HPLC measurements of pyridinium crosslinks.
Scand J Clin Lab Invest Suppl. 1997;227:80-3.
61. Prockop D J & Udenfriend S.
Aspecific method for the analysis of hydroxyproline in tissues and urine.
Anal.Biochem. 1:228-39, 1960.
62. J. Y. Fu, D. Muller. Institute for bone and joint disorders and cancer, Bayer Corporation, west Haven, Connecticut 06516, USA
Simple, rapid Enzyme-linked Immunosorbent Assay (ELISA) for the determination of rat osteocacin.
Cal Tissue Int. 64 (3), March 1999
Refer a Friend
Link To Us
Bookmark Us